On downstream of the signaling pathway, the authors demonstrated that Tau blocked the mesenchymalization of EGFR glioma cells by inhibiting NF-κB phosphorylation and by reducing the amount of TAZ protein. This evidence concerns the gene NFKB1 and glioma.